Dermatology
News
Review estimates acne risk with JAK inhibitor therapy
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
News
Topical ivermectin study sheds light on dysbiosis in rosacea
Research over the past decade has also started to look at the potential role of the skin microbiome in the disease process, but answers have...
News
Dupilumab-associated lymphoid reactions require caution
In cases involving unexpected responses or atypical presentations, clinicians must have a low threshold for stopping dupilumab.
News
Survey finds oral minoxidil shortage in Washington-area pharmacies
The drug’s popularity as a hair-loss treatment may be leading to decreased supplies.
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News
Review finds no CV or VTE risk signal with use of JAK inhibitors for skin indications
Of the 35 trials studied, most involved patients with atopic dermatitis.
News
Novel hydrogel holds promise for skin regeneration
The first clinical trials for treating complex diabetic wounds are planned for early 2024.
News
Systematic review spotlights the use of nutraceuticals for acne
Zinc was the most studied nutraceutical, but there was substantial heterogeneity in the results.
News
Adolescents with atopic dermatitis more likely to have experienced bullying, study finds
“Clinicians, families, and schools should address and monitor bullying among adolescents.”
News
FDA approves fixed dose combination topical treatment for acne
The new treatment combines three approved acne products for once-daily use.